Trial Profile
Follow-up study with retarded release phosphatidylcholine in ulcerative colitis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Aug 2011
Price :
$35
*
At a glance
- Drugs Phosphatidylcholine (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 15 Aug 2011 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 15 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jul 2007 New trial record.